Gain invaluable insights into advancing the discovery & development of immunotherapies to treat cancer & autoimmune diseases. Aligned with current industry trends, the 2026 programme will provide exclusive insights into cell-based therapeutics approaches, cytokine therapies and tolerization immunotherapies

Unlock the power of multi-omics approaches in immunotherapy. Thought-leaders will be discussing the utilization of spatial technologies in immunotherapy research, single cell sequencing & digital pathology for immune-oncology

Be at the forefront of nextgen targets & novel therapeutic strategies innovations. Hear about advancements in the discovery of best-in-class therapeutic antibodies, biomarker discovery & validation and the latest technological approaches

Take a deep dive into using translational models in immuno-oncology. Gain invaluable insights into in vivo and in vitro approaches, humanized & 3D mouse models and the role of the tumour microenvironment in ensuring clinical success